Table 2.
Baseline characteristics of the patients.
| Infection group | Non-infection group | |||
|---|---|---|---|---|
| CDSS non-DIC | CDSS DIC | CDSS non-DIC | CDSS DIC | |
| Age (years) | 50.3 ± 14.8 | 52.0 ± 13.0 | 48.2 ± 13.6 | 47.0 ± 15.4 |
| Male:female | 57:48 | 79:51 | 194:164 | 84:76 |
| APACHE II score | 13.8 ± 8.7 | 22.6 ± 12.0a | 10.8 ± 5.5b | 19.7 ± 10.4a |
| SOFA score | 4.7 ± 4.3 | 10.3 ± 5.2a | 3.0 ± 2.7b | 8.8 ± 5.0a,b |
| SIRS score | 2.2 ± 1.2 | 2.9 ± 1.0a | 1.6 ± 1.2b | 2.4 ± 1.1a,b |
| 28-day mortality | 21/105, 20.0% | 86/130, 66.2%a | 25/358, 7.0%b | 68/160, 42.5%a,b |
DIC, disseminated intravascular coagulation; CDSS, Chinese DIC Scoring System; JMHW, Japanese Ministry of Health and Welfare; ISTH, International Society on Thrombosis and Haemostasis; JAAM, Japanese Association for Acute Medicine; APACHE, Acute Physiology and Chronic Health Evaluation; SOFA, Sequential Organ Failure Assessment; SIRS, systemic inflammation response syndrome. ap < 0.05 between CDSS DIC and CDSS non-DIC; bp < 0.05 between infection and non-infection.